RLMD

NASD Relmada Therapeutics Inc
Oct 2, 2026 · 7:04 PM ET LAST TRADE Market Closed

$3.67 ↑ +0.07 (+1.81%) Trading Up from the previous close of $3.60, $0.07 below the day’s high of $3.73

YTD change
-24.12%
vs 20-day SMA
-10.52%
vs 200-day SMA
-32.92%

Price ranges

Previous day
$3.65 $3.80
open $3.73 close $3.66
-$0.07 (-1.88%)
Today
$3.60 $3.73
open $3.72 now $3.67
-$0.06 (-1.48%)
Past week
$3.65 $3.89
from $3.81 now $3.67
-$0.15 (-3.81%)
Past month
$3.65 $4.65
from $4.54 now $3.67
-$0.88 (-19.27%)
This year
$3.22 $8.00
from $4.83 now $3.67
-$1.17 (-24.12%)

Price & Performance

-3.33 (-47.64%) / 6M

$3.32$4.95$6.57$8.20Apr 2Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 93.2% away from all-time highs of $54.00
  • RLMD is down 24% since the beginning of the year
  • RLMD is up 38% over the past 12 months
  • RLMD is down 19% over the past 1 month
  • 13% of all RLMD investors are betting against RLMD

RLMD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +37.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.11
Earnings momentum +24.1% Quarterly EPS growth
Quarterly change +24.1%

Valuation

P/E ratio N/A
Enterprise value $193.6M
Beta 1.72

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$217.7M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $411.7M

Relmada Therapeutics, Inc. engages in the development of clinical-stage drugs. The firm's pipeline includes NDV-01 and Sepranolone. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,149.85 -0.62%
JNJ Johnson & Johnson $258.66 -2.30%
ABBV AbbVie, Inc. $259.93 -0.63%
MRK Merck & Co., Inc. $143.81 -1.03%
RHHVF Roche Holding Ltd $442.60 +6.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.